Literature DB >> 17460522

The natural history of conservatively managed symptomatic intramedullary spinal cord cavernomas.

Siddharth Kharkar, John Shuck, James Conway, Daniele Rigamonti.   

Abstract

OBJECTIVE: The presentation and natural history of untreated, symptomatic intramedullary spinal cavernomas at our institution were analyzed. The objective is to provide additional information regarding the natural history of conservatively managed, symptomatic, intramedullary spinal cord cavernous malformations.
METHODS: The medical records of patients treated in our institution between 1989 and 2002 were reviewed to identify those with intramedullary cavernomas. The medical, radiological, surgical, and pathological records from these patients were retrospectively reviewed and analyzed.
RESULTS: Fourteen patients were included in the study. The mean age at presentation was 42 years. Four lesions (29%) were located in the cervical region and 10 lesions (71%) were present in the thoracolumbar spinal cord. All patients were symptomatic at the time of presentation. In this cohort of 14 patients, 10 patients (71%) were conservatively managed. For these patients, the mean duration of symptoms before presentation was 10 months. The mean duration of follow-up from the time of presentation was 80 months. The median McCormick grade for conservatively treated patients at presentation was II. During this period, none of the conservatively managed patients had an acute intramedullary bleed. In nine patients, the McCormick grade at the last follow-up evaluation was the same as or better than their score at presentation. Four patients (29%) were treated surgically. The mean duration of symptoms before presentation was 33 months. The mean duration of follow-up from the time of presentation was 42 months. In two surgical patients, the McCormick grade at the last follow-up evaluation remained unchanged compared with their score at presentation, whereas the McCormick grade improved in one patient and deteriorated in another patient.
CONCLUSION: This cohort of conservatively managed patients with symptomatic, intramedullary spinal cord cavernomas was clinically stable throughout the follow-up period. In this series, patients harboring symptomatic spinal cord cavernous malformation did not have significant, permanent neurological decline during the follow-up period when treated with the conservative approach of observation. This data provides additional information for determining the appropriate treatment strategy for patients with intramedullary spinal cavernomas.

Entities:  

Mesh:

Year:  2007        PMID: 17460522     DOI: 10.1227/01.NEU.0000255437.36742.15

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  18 in total

Review 1.  Management of hemorrhage from cavernous malformations.

Authors:  Sachin Batra; Karen Rigamonti; Daniele Rigamonti
Journal:  Curr Atheroscler Rep       Date:  2012-08       Impact factor: 5.113

Review 2.  Pediatric intramedullary cavernous malformation of the conus medullaris: case report and review of the literature.

Authors:  Mahmoud Reza Khalatbari; Mehrdokht Hamidi; Yashar Moharamzad
Journal:  Childs Nerv Syst       Date:  2010-12-01       Impact factor: 1.475

Review 3.  Cavernous malformations: natural history, diagnosis and treatment.

Authors:  Sachin Batra; Doris Lin; Pablo F Recinos; Jun Zhang; Daniele Rigamonti
Journal:  Nat Rev Neurol       Date:  2009-12       Impact factor: 42.937

4.  Symptomatic spinal cavernous malformations: indication for microsurgical treatment and outcome.

Authors:  Homajoun Maslehaty; Harald Barth; Athanassios K Petridis; Alexandros Doukas; Hubertus Maximilian Mehdorn
Journal:  Eur Spine J       Date:  2011-07-14       Impact factor: 3.134

5.  Natural history of intramedullary spinal cord ependymoma in patients preferring nonoperative treatment.

Authors:  Bedjan Behmanesh; Florian Gessler; Stephan Dützmann; Daniel Dubinski; Lioba Imoehl; Volker Seifert; Matthias Setzer; Gerhard Marquardt
Journal:  J Neurooncol       Date:  2017-06-30       Impact factor: 4.130

6.  A retrospective and consecutive analysis of the epidemiology and management of spinal cavernomas over the last 20 years in a single center.

Authors:  Ardeshir Ardeshiri; Neriman Özkan; Bixia Chen; Klaus-Peter Stein; Dorothea Miller; Bernd-Otto Hütter; Ibrahim Erol Sandalcioglu; Ulrich Sure
Journal:  Neurosurg Rev       Date:  2015-12-02       Impact factor: 3.042

7.  Vascular diseases of the spinal cord: a review.

Authors:  Mirjam Rachel Heldner; Marcel Arnold; Krassen Nedeltchev; Jan Gralla; Jürgen Beck; Urs Fischer
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

8.  MR imaging features that distinguish spinal cavernous angioma from hemorrhagic ependymoma and serial MRI changes in cavernous angioma.

Authors:  Inhwan Jeon; Woo Sang Jung; Sang Hyun Suh; Tae-Sub Chung; Yong-Eun Cho; Sung Jun Ahn
Journal:  J Neurooncol       Date:  2016-08-16       Impact factor: 4.130

Review 9.  Intramedullary spinal cord cavernous malformations presenting with unexplained chest pain: case report and review of the literature.

Authors:  Salvatore Savasta; Mattia Algeri; Elisabetta De Sando; Alessandro Lozza; Georgia Mussati; Davide Locatelli; Gian Luigi Marseglia
Journal:  Childs Nerv Syst       Date:  2012-10-21       Impact factor: 1.475

10.  Intramedullary cavernoma presenting with hematomyelia: report of two girls.

Authors:  Erwin M J Cornips; Pauline A C P Vinken; Mariel Ter Laak-Poort; Emile A M Beuls; Jacobine Weber; Johannes S H Vles
Journal:  Childs Nerv Syst       Date:  2009-10-29       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.